Jazz Pharmaceuticals: Relief Rally On 2026 Oxybate Franchise’s Outlook (NASDAQ:JAZZ)

Core Insights - The Growth Stock Forum focuses on identifying attractive growth stocks, particularly in the biotech sector, emphasizing risk/reward situations [1] - The biotech Top Picks of the forum achieved a remarkable increase of 137.6% last year, with a compound annual growth rate (CAGR) of 37.2% since 2017 [1] - The core portfolio, LTGP, has also demonstrated a mid-20s CAGR, indicating strong performance in the long-term investment strategy [1]